- PhD, State University of New York at Buffalo
- Postdoc, University of Illinois, Chicago
Biochemistry, Biotechnology, Cancer Biology, Cardiovascular Biology, Epigenetics, Experimental Pathology, Immunology, Infectious Diseases/Biodefense, Metabolism, Molecular Biology, Molecular Pharmacology, Structural Biology, Translational Science
Nanotechnologies for targeted drug delivery
Dr. Kester has research interests that include the design, characterization and validation of nanotechnologies for targeted drug delivery. His laboratory has evaluated nanoliposomes, nanodendrimers and nanocolloids as effective drug delivery vehicles for pharmacological and molecular agents. Recent work focuses on nontoxic nanoscale systemic delivery systems for hydrophobic pro-apoptotic lipids as well as siRNAs that target mutated tumorigenic proteins. Dr. Kester has consulted with, or helped found, several companies that have the license to his "nano Solutions". In addition, Dr.Kester is a co-author of Integrated Pharmacology, published by Elsevier, Ltd., which was just recognized as a "highly commended textbook" by the British Medical Society.